MSCs can be delivered systemically through an IV or directly into a target area. This guide explains the difference, when each is used, and how patients us
Mesenchymal stem cells (MSCs) are studied for many wellness and joint-support uses. One of the first questions patients ask is whether MSCs should be delivered by IV or directly into a target area.
This guide explains the difference.
MSCs are signaling cells that respond to inflammation. Once in the body, they:
For patients researching options locally, our Bangkok regenerative clinic publishes physician credentials and program details openly.
The way MSCs are delivered changes where they act most strongly.
IV MSC therapy delivers cells into the bloodstream. From there, MSCs may:
It is generally used for systemic, whole-body goals.
Local MSC therapy delivers cells directly into a target area, such as a joint, tendon, or skin region. This approach:
It is generally used for specific joint or tissue concerns.
| Feature | IV MSCs Therapy | Local MSCs Therapy |
|---|---|---|
| Delivery route | Bloodstream | Direct injection |
| Primary focus | Whole-body, systemic | Specific tissue or joint |
| Common use | Wellness, immune support | Joint, tendon, skin support |
| Onset of changes | Gradual, weeks to months | Often more focused, weeks |
| Cell distribution | Widely circulated | Concentrated locally |
Patients often consider IV MSCs therapy for:
Patients often consider local MSCs therapy for:
The difference between IV and local MSCs therapy comes down to where the cells act. IV delivery supports systemic, whole-body goals. Local delivery focuses on specific tissues. The right choice depends on the patient and the plan. Learn more about our IV nutrient support program.
This article is for general informational and educational purposes only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before considering stem cell therapy.